Diabetic macular edema: pathogenesis and treatment

Area of Science:

• Ophthalmology
• Diabetology
• Medical Research

Background:

• Diabetic macular edema (DME) is a leading cause of vision impairment in diabetic individuals.
• The underlying mechanisms of DME are complex and multifactorial.
• Current standard treatment, laser photocoagulation, is not effective for all patients.

Purpose of the Study:

• To review the various factors and mechanisms contributing to the development of diabetic macular edema.
• To explore alternative and advanced therapeutic strategies for DME management.

Main Methods:

• Literature review of existing studies on diabetic macular edema.
• Analysis of etiological factors including vasoactive substances, biochemical pathways, and anatomical changes.
• Evaluation of current and proposed treatment modalities.

Main Results:

• Multiple factors contribute to DME pathogenesis, including vascular leakage and inflammation.
• Laser therapy has limitations in treating resistant DME cases.
• Emerging evidence suggests combined pharmacologic and surgical approaches show promise.

Conclusions:

• Understanding the multifactorial nature of DME is crucial for effective treatment.
• Combined pharmacologic and surgical interventions may represent a superior therapeutic strategy for managing refractory diabetic macular edema.
• Further research is warranted to optimize combination therapies for DME.